Halozyme Therapeutics Inc

The current institutional shareholding score of Halozyme Therapeutics Inc is 10.00, ranking 1 out of 157 in the Pharmaceuticals industry. The latest institutional shareholding proportion is 117.14%, representing a quarter-over-quarter increase of 10.45%. The largest institutional shareholder is Bill Nygren | OAKMX, holding a total of 703.13K shares, representing 0.63% of shares outstanding, with 186.36% increase in holdings.